 Home > Active Ingredient News > Antitumor Therapy > Interpretation of the update points of "CSCO Guidelines for the Diagnosis and Treatment of Non-Small Cell Lung Cancer 2021"

Interpretation of the update points of "CSCO Guidelines for the Diagnosis and Treatment of Non-Small Cell Lung Cancer 2021"

 Last Update: 2022-03-05
 Source: Internet
 Author: User

Tags

lung muscle

hemorrhoids treatment cvs

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Guideline name: Interpretation of the update points of "CSCO Guidelines for the Diagnosis and Treatment of Non-Small Cell Lung Cancer 2021"

Guide name:

English title:

Publisher: National Cancer Center

Release date: 2022-02-10

Release date:

brief introduction:

Non-small cell lung cancer is the most common pathological type of lung cancer
.

In recent years, with the development of medical technology, new treatment methods including targeted therapy and immunotherapy have improved the prognosis of patients with non-small cell lung cancer

Non-small cell lung cancer is the most common pathological type of lung cancer

Source: Journal of Practical Oncology

source:

Download address: Please download Metz Medical APP to download ( Metz Medical APP points download)

Download address: Meisi Medical APP
Tips: 78% of users have downloaded the Meisi Medical APP , which is more convenient to read and communicate, please scan the QR code to directly download the APP Meisi Medical APP

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Cediranib

CAS No.: 288383-20-0

$22/KG EXW

Upadacitinib hemihydrate API

CAS No.: 2050057-56-0

Pharmacy Grade

$35-45/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.